News Focus
News Focus
icon url

Bonou2

11/22/16 2:10 PM

#80608 RE: frrol #80605

What it needs to get back to a fair course. 5-6 dollars with the messages who normally .. Maybe but it's Biogen to not have to pay too big a price.
icon url

Chemdeps

11/22/16 3:02 PM

#80622 RE: frrol #80605

I downloaded the pdf announcement from AVXL's website and this is what is at the top of the document:

Investigational Treatment suggests to curb Cognitive and Functional Decline
- Full data to be presented at CTAD 2016 -
NEW YORK, NY – November 22, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL)
today announced a positive 41-week update from its Phase 2a study in mild-to-moderate Alzheimer’s disease (AD)
patients for ANAVEX 2-73, which targets cellular homeostasis
.